Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Patents
  • Published:

Winning the race to invent

Sometimes choosing the right finish line is often more important than being swifter.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Morgenthalerv. Scudder, 11 App. D.C. 264 (D.C. Cir.1897).

  2. These rules as stated are simplified and riddled with exceptions.

  3. See, for example, Amgen, Inc. v. ChugaiPharmaceutical Co., Ltd., 927 F.2d 1200 (Fed. Cir. 1991); Fiers v. Sugano, 984 F.2d 1164 (Fed. Cir. 1993).

  4. Burroughs Wellcome Co. v. BarrLaboratories, Inc., 40F.3d 1223 (Fed. Cir. 1994); Staehelin v. Secher, 24 USPQ2d 1513 (Bd. Pat. App. & Int. 1992).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meredith, R. Winning the race to invent. Nat Biotechnol 15, 283–284 (1997). https://doi.org/10.1038/nbt0397-283

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0397-283

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing